{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35154350", "DateRevised": {"Year": "2022", "Month": "02", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "15"}], "Language": ["eng"], "ELocationID": ["6730559", "10.1155/2022/6730559"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2022", "PubDate": {"Year": "2022"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Paeoniflorin Enhances the Sensitivity of ER-Positive Breast Cancer Cells to Tamoxifen through Promoting Sirtuin 4.", "Pagination": {"StartPage": "6730559", "MedlinePgn": "6730559"}, "Abstract": {"AbstractText": ["Tamoxifen is an effective drug for treating patients with advanced estrogen receptor-positive (ER+) breast cancer (BC), but not for all ER\u2009+\u2009BC patients. Drug tolerance is the biggest obstacle. In this study, we designed an experiment to investigate whether paeoniflorin affects the ER\u2009+\u2009BC cell's sensitivity to tamoxifen in the T47D and MCF-7 cell lines. Herein, we found that paeoniflorin inhibited cell proliferation without inducing apoptosis. However, it enhanced tamoxifen-induced apoptosis in both cell lines. Immunoblotting revealed that paeoniflorin significantly increased the already elevated Bax/Bcl2 protein expression ratio and the caspase 3 activity levels, both induced by tamoxifen. Paeoniflorin was also found to increase SIRT4 expression, and deletion of SIRT4 could significantly reverse the inhibition of cell proliferation induced by paeoniflorin and significantly decrease paeoniflorin-enhanced apoptosis induced by tamoxifen. Moreover, protein expression detection revealed that paeoniflorin enhanced the tamoxifen-induced inhibition of STAT3 activation. Besides, the deletion of SIRT4 could significantly increase STAT3 activation in the T47D and MCF-7 cells. In conclusion, paeoniflorin suppressed STAT3 activation to enhance the sensitivity of ER-positive breast cancer cells to tamoxifen through promoting SIRT4 expression."], "CopyrightInformation": "Copyright \u00a9 2022 Pei Zhang et al."}, "AuthorList": [{"Identifier": ["0000-0002-6917-8945"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Yunnan Open University, Yunnan Vocational and Technical College of National Defense Industry, Kunming 650500, China."}], "LastName": "Zhang", "ForeName": "Pei", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medical, Yunnan University of Business Management, Kunming 650500, China."}], "LastName": "Wu", "ForeName": "Nan", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Botanical Garden of Medicinal Plants, Nanning 530023, China."}], "LastName": "Song", "ForeName": "Zhi-Jun", "Initials": "ZJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sichuan Kelun Pharmaceutical Research Institute, Chengdu 610000, China."}], "LastName": "Tai", "ForeName": "Zheng-Fu", "Initials": "ZF"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors declare that there are no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Visvanathan K., Fabian C. J., Bantug E., et al. Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update. Journal of Clinical Oncology . 2019;37(33):3152\u20133165. doi: 10.1200/jco.19.01472.", "ArticleIdList": ["10.1200/jco.19.01472", "31479306"]}, {"Citation": "Blok E. J., Kroep J. R., Meershoek-Klein Kranenbarg E., et al. Optimal duration of extended adjuvant endocrine therapy for early breast cancer; results of the IDEAL trial (BOOG 2006-05) Journal of the National Cancer Institute: Journal of the National Cancer Institute (Bethesda) . 2018;110(1):40\u201348. doi: 10.1093/jnci/djx134.", "ArticleIdList": ["10.1093/jnci/djx134", "28922787"]}, {"Citation": "J\u00f6gi A., Ehinger A., Hartman L., Alkner S. Expression of HIF-1\u03b1 is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer. PLoS One . 2019;14(12) doi: 10.1371/journal.pone.0226150.e0226150", "ArticleIdList": ["10.1371/journal.pone.0226150", "PMC6903737", "31821370"]}, {"Citation": "Chang M.-S. Tamoxifen resistance in breast cancer. Biomolecules and Therapeutics . 2012;20(3):256\u2013267. doi: 10.4062/biomolther.2012.20.3.256.", "ArticleIdList": ["10.4062/biomolther.2012.20.3.256", "PMC3794521", "24130921"]}, {"Citation": "Ali S., Rasool M., Chaoudhry H., et al. Molecular mechanisms and mode of tamoxifen resistance in breast cancer. Bioinformation . 2016;12(3):135\u2013139. doi: 10.6026/97320630012135.", "ArticleIdList": ["10.6026/97320630012135", "PMC5267957", "28149048"]}, {"Citation": "Milena R.-L., Victoria V., Nelson R., Magda S., Peter Z. Tamoxifen resistance: emerging molecular targets. International Journal of Molecular Sciences . 2016;17(8):p. 1357.", "ArticleIdList": ["PMC5000752", "27548161"]}, {"Citation": "Xin Q., Yuan R., Shi W., Zhu Z., Wang Y., Cong W. A review for the anti-inflammatory effects of paeoniflorin in inflammatory disorders. Life Sciences . 2019;237 doi: 10.1016/j.lfs.2019.116925.116925", "ArticleIdList": ["10.1016/j.lfs.2019.116925", "31610201"]}, {"Citation": "Ho L. A., Scolaro L., Thomas E., Quirk B. C., Fuller R. O. Developing tamoxifen-based chemical probes for use with a dual-modality fluorescence and optical coherence tomography imaging needle. Australian Journal of Chemistry . 2020;73"}, {"Citation": "Zhang L., Zhang S. Modulating bcl-2 family proteins and caspase-3 in induction of apoptosis by paeoniflorin in human cervical cancer cells. Phytotherapy Research . 2011;25(10):1551\u20131557. doi: 10.1002/ptr.3534.", "ArticleIdList": ["10.1002/ptr.3534", "21698669"]}, {"Citation": "Zhang B. Paeoniflorin elicits the anti-proliferative effects on glioma cell via targeting translocator protein 18KDa. Journal of Pharmacological Sciences . 2021;145(1):115\u2013121.", "ArticleIdList": ["33357769"]}, {"Citation": "Fang S., Zhu W., Zhang Y., Shu Y., Liu P. Paeoniflorin modulates multidrug resistance of a human gastric cancer cell line via the inhibition of NF-\u03baB activation. Molecular Medicine Reports . 2012;5(2):351\u2013356. doi: 10.3892/mmr.2011.652.", "ArticleIdList": ["10.3892/mmr.2011.652", "22051979"]}, {"Citation": "Wu H., Li W., Wang T., Shu Y., Liu P. Paeoniflorin suppress NF-\u03baB activation through modulation of I\u03baB\u03b1 and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells. Biomedicine & Pharmacotherapy . 2008;62(9):659\u2013666. doi: 10.1016/j.biopha.2008.08.002.", "ArticleIdList": ["10.1016/j.biopha.2008.08.002", "18809274"]}, {"Citation": "Zhang J., Yu K., Han X. Paeoniflorin influences breast cancer cell proliferation and invasion via inhibition of the Notch-1 signaling pathway. Molecular Medicine Reports . 2018;17(1):1321\u20131325.", "ArticleIdList": ["29115554"]}, {"Citation": "Zhou Z., Wang S., Song C., Hu Z. Paeoniflorin prevents hypoxia-induced epithelial\u2013mesenchymal transition in human breast cancer cells. OncoTargets and Therapy . 2016;9:2511\u20132518. doi: 10.2147/ott.s102422.", "ArticleIdList": ["10.2147/ott.s102422", "PMC4854234", "27175085"]}, {"Citation": "Yaln G. D., Colak M. SIRT4 prevents excitotoxicity via modulating glutamate metabolism in glioma cells. Human & Experimental Toxicology . 2020;39(1)096032712090714", "ArticleIdList": ["32081049"]}, {"Citation": "Xing J., Li J., Fu L., Gai J., Guan J., Li Q. SIRT4 enhances the sensitivity of ER\u2010positive breast cancer to tamoxifen by inhibiting the IL\u20106/STAT3 signal pathway. Cancer Medicine . 2019;8(16):7086\u20137097. doi: 10.1002/cam4.2557.", "ArticleIdList": ["10.1002/cam4.2557", "PMC6853819", "31573734"]}, {"Citation": "Tao J., Zhang J., Ling Y., McCall C. E., Liu T. F. Mitochondrial sirtuin 4 resolves immune tolerance in monocytes by rebalancing glycolysis and glucose oxidation homeostasis. Frontiers in Immunology . 2018;9:p. 419. doi: 10.3389/fimmu.2018.00419.", "ArticleIdList": ["10.3389/fimmu.2018.00419", "PMC5854658", "29593712"]}, {"Citation": "Porporato P. E., Filigheddu N., Pedro J. M. B.-S., Kroemer G., Galluzzi L. Mitochondrial metabolism and cancer. Cell Research . 2018;28(3):265\u2013280. doi: 10.1038/cr.2017.155.", "ArticleIdList": ["10.1038/cr.2017.155", "PMC5835768", "29219147"]}, {"Citation": "Gaude E., Frezza C. Defects in mitochondrial metabolism and cancer. Cancer & Metabolism . 2014;2(1):10\u201319. doi: 10.1186/2049-3002-2-10.", "ArticleIdList": ["10.1186/2049-3002-2-10", "PMC4108232", "25057353"]}, {"Citation": "Cheng R., Liu Y.-J., Cui J.-W., et al. Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells. Oncotarget . 2017;8(18):30252\u201330264. doi: 10.18632/oncotarget.16325.", "ArticleIdList": ["10.18632/oncotarget.16325", "PMC5444740", "28415819"]}, {"Citation": "Santucci C., Carioli G., Bertuccio P., Malvezzi M., Vecchia C. L. Progress in cancer mortality, incidence, and survival: a global overview. European Journal of Cancer Prevention . 2020;1 doi: 10.1097/cej.0000000000000594.", "ArticleIdList": ["10.1097/cej.0000000000000594", "32740162"]}, {"Citation": "Pilleron S., Soto\u2010Perez\u2010de\u2010Celis E., Vignat J., et al. Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050. International Journal of Cancer . 2021;148(3):601\u2013608. doi: 10.1002/ijc.33232.", "ArticleIdList": ["10.1002/ijc.33232", "PMC7754149", "32706917"]}, {"Citation": "\u00c1lvarez-Aznar A., Mart\u00ednez-Corral I., Daubel N., Betsholtz C., M\u00e4kinen T., Gaengel K. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines. Transgenic Research . 2020;29(1):53\u201368.", "ArticleIdList": ["PMC7000517", "31641921"]}, {"Citation": "Xiang Y., Zhang Q., Wei S., Huang C., Li Z., Gao Y. Paeoniflorin: a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities. Journal of Pharmacy and Pharmacology . 2020;72(4):483\u2013495. doi: 10.1111/jphp.13204.", "ArticleIdList": ["10.1111/jphp.13204", "31858611"]}, {"Citation": "Lee C. J., Jordan M. A., Wilson L., Lee S. Y., Lee M. N. Effects of Paeoniflorin, Baicalein, Hesperidin and Oleanolic Acid on Human Breast and Prostate Cancer Cells . Philadelphia, PA, USA: AACR; 2009."}, {"Citation": "Yu S., Kim T., Yoo K. H., Kang K. The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer. Biochemical and Biophysical Research Communications . 2017;486(3):752\u2013758. doi: 10.1016/j.bbrc.2017.03.114.", "ArticleIdList": ["10.1016/j.bbrc.2017.03.114", "28342866"]}, {"Citation": "Yang N., Cui H., Han F., et al. Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling. Oncology letters . 2016;12(2):1471\u20131476. doi: 10.3892/ol.2016.4761.", "ArticleIdList": ["10.3892/ol.2016.4761", "PMC4950818", "27446455"]}, {"Citation": "Li Y., Gong L., Qi R., et al. Paeoniflorin suppresses pancreatic cancer cell growth by upregulating HTRA3 expression. Drug Design, Development and Therapy . 2017;11:2481\u20132491. doi: 10.2147/dddt.s134518.", "ArticleIdList": ["10.2147/dddt.s134518", "PMC5574596", "28860718"]}, {"Citation": "Fernandez-Marcos P. J., Serrano M. Sirt4: the glutamine gatekeeper. Cancer Cell . 2013;23(4):427\u2013428. doi: 10.1016/j.ccr.2013.04.003.", "ArticleIdList": ["10.1016/j.ccr.2013.04.003", "PMC4851233", "23597559"]}, {"Citation": "Jeong S. M., Xiao C., Finley L. W. S., et al. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell . 2013;23(4):450\u2013463. doi: 10.1016/j.ccr.2013.02.024.", "ArticleIdList": ["10.1016/j.ccr.2013.02.024", "PMC3650305", "23562301"]}, {"Citation": "Huang G., Cheng J., Yu F., et al. Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer. Oncology Reports . 2016;35(5):2801\u20132810. doi: 10.3892/or.2016.4685.", "ArticleIdList": ["10.3892/or.2016.4685", "26986234"]}, {"Citation": "Han Y., Zhou S., Coetzee S., Chen A. SIRT4 and its roles in energy and redox metabolism in health, disease and during exercise. Frontiers in Physiology . 2019;10:p. 1006. doi: 10.3389/fphys.2019.01006.", "ArticleIdList": ["10.3389/fphys.2019.01006", "PMC6695564", "31447696"]}, {"Citation": "Santoro M., Guido C., De Amicis F., et al. Bergapten induces metabolic reprogramming in breast cancer cells. Oncology Reports . 2016;35(1):568\u2013576. doi: 10.3892/or.2015.4327.", "ArticleIdList": ["10.3892/or.2015.4327", "26459431"]}, {"Citation": "Altman B. J., Stine Z. E., Dang C. V. From Krebs to clinic: glutamine metabolism to cancer therapy. Nature Reviews Cancer . 2016;16(10):619\u2013634. doi: 10.1038/nrc.2016.71.", "ArticleIdList": ["10.1038/nrc.2016.71", "PMC5484415", "27492215"]}, {"Citation": "Hensley C. T., Wasti A. T., Deberardinis R. J. Glutamine and cancer: cell biology, physiology, and clinical opportunities. Journal of Clinical Investigation . 2013;123(9):3678\u20133684. doi: 10.1172/jci69600.", "ArticleIdList": ["10.1172/jci69600", "PMC3754270", "23999442"]}, {"Citation": "Komlos D., Mann K. D., Zhuo Y. Glutamate dehydrogenase 1 and SIRT4 regulate glial development. Glia . 2013;13 doi: 10.1002/glia.22442.", "ArticleIdList": ["10.1002/glia.22442", "PMC3552040", "23281078"]}, {"Citation": "Tomaselli D., Steegborn C., Mai A., Rotili D. Sirt4: a multifaceted enzyme at the crossroads of mitochondrial metabolism and cancer. Frontiers in Oncology . 2020;10:p. 474. doi: 10.3389/fonc.2020.00474.", "ArticleIdList": ["10.3389/fonc.2020.00474", "PMC7177044", "32373514"]}, {"Citation": "Shi Q., Liu T., Zhang X., et al. Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer. Oncology letters . 2016;12(4):2606\u20132612. doi: 10.3892/ol.2016.5021.", "ArticleIdList": ["10.3892/ol.2016.5021", "PMC5038587", "27698834"]}, {"Citation": "Nizam U., Rae-Kwon K., Ki-Chun Y. Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer. Cancer Science . 2019;106(6):718\u2013725.", "ArticleIdList": ["PMC4471798", "25854938"]}, {"Citation": "Huang J., Huang L.-q., He H.-s., et al. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes multiple myeloma resistance through the JAK2/STAT3 pathway. Life Sciences . 2020;257 doi: 10.1016/j.lfs.2020.118088.118088", "ArticleIdList": ["10.1016/j.lfs.2020.118088", "32663573"]}, {"Citation": "Bui Q. T., Im J. H., Jeong S. B., et al. Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer. Cancer Letters . 2017;390:115\u2013125. doi: 10.1016/j.canlet.2017.01.014.", "ArticleIdList": ["10.1016/j.canlet.2017.01.014", "28108315"]}, {"Citation": "Yi E. H., Lee C. S., Lee J.-K., et al. STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cells. Molecular Cancer Research . 2013;11(1):31\u201342. doi: 10.1158/1541-7786.mcr-12-0217.", "ArticleIdList": ["10.1158/1541-7786.mcr-12-0217", "23074171"]}, {"Citation": "Mcdaniel L. M., Shajahan A. N., Clarke R. Abstract 4601: XBP1 regulated function of c-MYC and BCL2 in antiestrogen resistance in breast cancer. Cancer Research . 2010;70(8):p. 4601. doi: 10.1158/1538-7445.am10-4601.", "ArticleIdList": ["10.1158/1538-7445.am10-4601"]}, {"Citation": "Yi X., Lou L., Wang J., Xiong J., Zhou S. Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway. Cancer Chemotherapy and Pharmacology . 2021;8:1\u201310. doi: 10.1007/s00280-021-04238-w.", "ArticleIdList": ["10.1007/s00280-021-04238-w", "33544209"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "10"}, {"Year": "2021", "Month": "9", "Day": "26"}, {"Year": "2021", "Month": "11", "Day": "10"}, {"Year": "2022", "Month": "2", "Day": "14", "Hour": "5", "Minute": "31"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["35154350", "PMC8831046", "10.1155/2022/6730559"]}}], "PubmedBookArticle": []}